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ABSTRACT
Biological activities of crude methanolic extracts from leaves, barks, twigs and roots of Enicosanthellum pulchrum were 
investigated in four bioassays. The antioxidant, 2,2-Diphenyl-1-picrylhydrazyl (DPPH) scavenging assay showed that 
bark and twig extracts showed high inhibitory activity with 60 and 56% inhibition at 1 mg/mL and IC50 values of 0.43 
± 0.04 and 0.64 ± 0.05 mg/mL, respectively. The bark and root extracts showed greater reducing power (FRAP) than 
several standard drugs used in the bioassay. Methanolic extracts of leaves, twigs and roots displayed strong cytotoxicity 
to breast cancer cell line (MCF-7), myelomonocytic leukaemia cell line (WEHI-3) and ovarian cancer cell line (CAOV-3); 
the IC50 of the leaf extract were 7.8 ± 0.85 µg/mL (MCF-7) and 9.0 ± 0.13 µg/mL (WEHI-3), while those for the twig and 
root extracts were 13.9 ± 0.35 and 7.3 ± 0.98 µg/mL (CAOV-3), respectively. In the antimicrobial assays, the extracts 
were tested against ten bacterial strains and two fungal strains. Bark and twig extracts displayed high inhibitory activity 
to Bacillus subtilis with 13.3 ± 0.57 and 12.0 ± 0.01 mm inhibition, respectively. In addition, the twig extract displayed 
better minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) compared with the bark 
extract (MIC 0.5 and 1.0 mg/mL, MBC 1.0 and 2.0 mg/mL, respectively). For antifungal activity, all extracts showed 
inhibition on Candida albicans but not on Aspergillus niger. The obtained results suggested that this plant may possibly 
contain bioactive compounds in the active extracts.
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ABSTRAK
Aktiviti biologi Enicosanthellum pulchrum bagi ekstrak kasar metanol daun, kulit, batang dan akar telah dikaji terhadap 
empat bioasai. Asai skaveng antioksidan, 2,2-Diphenyl-1-picrylhydrazyl (DPPH) mendedahkan bahawa ekstrak kulit dan 
batang menunjukkan aktiviti perencatan yang tinggi dengan perencatan sebanyak 60 dan 56% pada kepekatan 1 mg/
mL, manakala nilai IC50 masing-masing adalah 0.43 ± 0.04 dan 0.64 ± 0.05 mg/mL. Ekstrak kulit dan akar menunjukkan 
kuasa pengurangan yang lebih besar (FRAP) berbanding dadah kawalan yang digunakan dalam bioasai ini. Ekstrak 
metanol daun, batang dan akar memaparkan sitotoksisiti yang kuat terhadap titisan sel kanser payudara (MCF-7), leukimia 
milomonositik (WEHI-3) dan kanser ovari (CAOV-3); nilai IC50 bagi ekstrak daun 7.8 ± 0.85 µg/mL (MCF-7), manakala 
ekstrak batang dan akar masing-masing adalah 13.9 ± 0.35 dan 7.3 ± 0.98 µg/mL (CAOV-3). Bagi asai antimikrob, ekstrak 
diuji terhadap sepuluh strain bakteria dan dua strain fungus. Ekstrak kulit dan batang memaparkan aktiviti perencatan 
yang tinggi terhadap bakteria bacillus subtilis dengan perencatan masing-masing sebanyak 13.3 ± 0.57 dan 12.0 ± 
0.01 mm. Bacaan bagi kepekatan perencatan minimum (MIC) dan kepekatan bakterisidal minimum (MBC) bagi kedua-
dua ekstrak menunjukkan ekstrak batang memberikan bacaan MIC dan MBC yang lebih baik berbanding ekstrak kulit 
dengan bacaan masing-masing sebanyak (MIC 0.5 dan 1.0 mg/mL, MBC 1.0 dan 2.0 mg/mL). Bagi aktiviti antifungus, 
semua ekstrak memberikan perencatan terhadap Candida albicans dan tidak pada Aspergillus niger. Keputusan yang 
diperoleh mencadangkan bahawa tumbuhan ini berkumungkinan mempunyai sebatian bioaktif daripada ekstrak aktif.
Kata kunci: Antikanser; antimikrob; antioksidan; ekstrak metanol; Enicosanthellum pulchrum 
INTRODUCTION
Natural products have been recognized as an important 
tool in the drug discovery process throughout this century 
(Agosta 1997; Sthrol 2000). Many studies have been 
conducted especially on plants in order to identify chemical 
compounds that can act as remedies for various diseases. 
In fact, plants have been reported to be used worldwide 
for medicinal purposes (Duke 2000). However, the search 
for biologically active compounds requires a bioassay 
procedure to detect a certain type of biological activity 
in the corresponding crude extract (Hostettmann et al. 
1997). The development of biological activity studies on 
the plant extracts and compounds in Malaysia actively 
began in the early 90’s (Jantan 2008). Some specific 
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bioassay method involving in vitro systems have been 
used to study biological activities such as anticancer, 
antiviral and antiparasitic (Jantan 2008). Several 
reports have been published regarding the study of the 
biological activity of extracts and compounds from local 
plants such as antimalarial, antimicrobial, antioxidant, 
anti-inflammatory and cytotoxic activities of Garcinia 
atroviridis, Sandoricum koetjape and Hedyotis species 
(Ahmad et al. 2005; Mackeen et al. 2002; Mat Ali et al. 
2004; Nik Rahman et al. 1999). Therefore, plant derived-
bioactive compounds have received considerable attention 
due to their therapeutic potential as antimicrobial, anti-
inflammatory, anticancer and antioxidant agents (Rathee 
et al. 2009).
 Enicosanthellum pulchrum (King) Heusden also 
known as family of ‘mempisang’ is a species from 
Annonaceae family (Burkill 1966). It was first discovered 
in the Coteau area at the border of Thailand and Malaysia. It 
is a coniferous tree that can grow to about 3-5 m tall (David 
et al. 1989). This plant is a highland plant which is confined 
to mountain forests at an altitude of 1200-1500 m (Ng et 
al. 1990). Phytochemical studies of this plant have shown 
several isoquinoline alkaloids such as (-)-asimilobine, 
(-)-anonaine, (-)-norliridine, liriodenine and (-)-scoulerine 
(Lavault et al. 1990) as well as azaantraquinone alkaloid 
such as cleistopholine (Nordin et al. 2012). However, to 
the best of our knowledge, only one biological activity has 
been reported so far for this plant which is anti-platelet 
activating factor (Nordin et al. 2012). In the current study, 
we investigated the presence of bioactive compounds from 
each part of E. pulchrum and its antioxidant, anticancer 
and antimicrobial potential in methanolic extracts. 
MATERIALS AND METHODS
CHEMICALS AND REAGENTS
2,2-Diphenyl-1-picrylhydrazyl (DPPH), fetal bovine serum 
(FBS), sodium nitrite, quercetin, trolox, ascorbic acid, sodium 
acetic acid and iron chloride were purchased from Sigma-
Aldrich. Dimetylsulfoxide (DMSO), acetic acid glacial, 
hydrocloride acid, methanol and ethanol were purchased 
from Merck Co. (Germany). 3-(4,5-Dimethylthiazol-2yl)-
2,5-diphenyltetrazolium bromide (MTT) from Invitrogen 
(Carlsbad, USA). RPMI-1640 medium (pH7.4) from Nacalai 
tesque (Japan) and Trypsin-EDTA 10X from Biowest (USA). 
CELL LINE AND PATHOGEN
Eleven cell lines including normal hepatic cells (WRL-
68), breast cancer cells (MCF-7 and MDA-MB231), 
human hepatocellular carcinoma cells (HepG2), colon 
adenocarcinoma cells (HT-29), normal colon cells (CCD-
841), ovarian cancer cells (CAOV-3, SKOV-3), prostate 
adenocarcinoma cells (PC3), myelomonocytic leukaemia 
cells (WEHI-3B) and human promyelocytic leukaemia 
cells (HL-60) were obtained from American Type 
Culture Collection (ATCC). Twelve pathogens in total, 
including ten bacteria strains, Bacillus cereus (B43), 
Bacillus subtilis (B145), Enterobacter cloacae (UMMC), 
Staphylococcus aureus (S1434), Salmonella typhimurium 
(S1211), Pseudomonas aeruginosa (ATCC 27853), Klebsiella 
pneumoniae (UMMC), Staphylococcus aureus (ATCC 
25923), Pasteurella multocida (UMMC) and Staphylococcus 
epidermidis (UMMC) as well as two fungal strains, Candida 
albicans (C523) and Aspergillus niger (A121) were used for 
antimicrobial assay.
PLANT PREPARATION
The plant E. pulchrum was collected from Cameron 
Highlands Montane Forest, Pahang. The specimen was 
identified by a botanist, the late Prof. Dr. Kamaruddin 
Mat Salleh from the Faculty of Science and Technology, 
Universiti Kebangsaan Malaysia. The voucher specimen 
(SM769) was deposited at the Herbarium of the Botany 
Department, UKM. Each plant including leaves, barks, twigs 
and roots were air-dried and ground to 40-60 mesh size 
before extracted with methanol by maceration technique. 
Evaporation of the solvents using rotary evaporator gave 
four crude methanolic extracts. 
DPPH RADICAL-SCAVENGING ACTIVITY
The DPPH assay was performed according to the modified 
method by Orhan et al. (2007) and Brem et al. (2004). 
Briefly, 100 μL of DMSO was added into each 96 wells. 
Then, 100 μL (1 mg/mL) of standard compounds or 
samples (1 mg/mL) were added into the first row. 
Subsequently, 10 μL (2.5 mg/mL) of stable DPPH free 
radical in DMSO were added to each well in a 96-well 
plate. Ascorbic acid (vitamin C) and quercetin were used 
as standard drug whereas blank solvent DMSO as the 
negative control. The absorbance was read at 517 nm using 
microplate absorbance reader (Infinite M200PRO) after 20 
min of incubation at room temperature. 
FERRIC REDUCING ANTIOXIDANT POWER (FRAP) ASSAY
Determination of the total antioxidant activity (FRAP assay) 
was using a modified method of Benzie and Strain (1999). 
The stock solutions included 300 mM acetate buffer (3.1g 
C2H3NaO2.3H2O and 16 mL C2H4O2), pH3.6, 10 mM TPTZ 
(2,4,6-tripyridyl-s-triazine) solution in 40 mM HCl and 20 
mM FeCl3.6H2O solution. The fresh working solution (FRAP 
reagent) was prepared by mixing 25 mL acetate buffer, 2.5 
mL TPTZ and 2.5 mL FeCl3.6H2O. 10 μL of samples (1 mg/
mL) and 300 μL FRAP reagent were added in each wells. 
Readings of the coloured product (ferrous tripyridyltriazine 
complex) were taken at 593 nm. 
CYTOTOXICITY ASSAY (MTT ASSAY)
All cells were grown in RPMI 1640 medium and maintained 
in 37°C incubator with 5% CO2 saturation. Different cell 
types were used to determine the cytotoxic effects of E. 
pulchrum extracts using the MTT assay. Confluent cells 
were centrifuged at 1800 rpm for 5 min and concentration 
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of cells was adjusted to 1 × 106 cells/mL. To measure cell 
viability, 100 μL of cells were seeded in a 96-well plate and 
incubated for 24 h at 37°C. Cells were then treated with the 
extracts and incubated for 24 h. After 24 h, MTT solution 
(5 mg/mL) was added in each well for 3 h. Absorbance 
was measured at 570 nm using an ELISA microplate reader. 
The results were shown as a percentage of control giving 
percentage cell viability after 24 h exposure to test agents 
(Cheah et al. 2011). Several positive controls such as 
tamoxifen, paclitaxel, cisplatin and vinblastin were used 
in the experiment.
DISC DIFFUSION ASSAY 
For bacterial disc diffusion assay, petri plates (9 cm) were 
prepared with 20 mL of a base layer of Nutrient Agar 
(DIFCO, Becton Dickinson, USA) whereas for the fungal disc 
diffusion assay, Patato dextrose agar (PDA) was used. Each 
petri plate was inoculated with 15 μL of each bacterial/
fungal suspension (106 CFU/mL). After being dried in a 
sterile hood, 6 mm diameter discs soaked with 10 μL of 
the extracts from E. pulchrum. Discs containing standards 
antibiotics were used as positive control. The plates were 
incubated for 24 h at 37°C. The diameters of the inhibition 
zones were evaluated in millimeters. All tests were 
performed in triplicate and the bacterial/fungal activity 
was expressed as the mean of inhibition diameters (mm).
DETERMINATION OF MIC AND MBC
The minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) of antibiotics and plant 
extracts were determined using the standard broth micro 
dilution method as described by Eloff (1998) using test 
bacteria that have been standardized to OD600 nm. Extracts 
were dissolved in 100% DMSO to obtain a concentration of 
1 mg/mL. Using a 96-well microtiter plate, nutrient broth, 
bacteria and extracts were dispensed into every well and 
labelled appropriately. Plates were covered and incubated 
at 37°C for 24 h. Control wells were loaded with nutrient 
broth and extracts with no bacteria added (wells 12 A-H), 
broth and bacteria with no extract (wells 11 A-H). Tecan 
micro plate reader (Infinite M200PRO) was used to quantify 
the optical density of the reactants in each well. The MBC 
of active extracts were determined by streaking on nutrient 
agar plates from wells that showed growth inhibition. The 
concentration of extract in the wells where there was no 
growth on plate was considered as the MBC.
STATISTICAL ANALYSIS
All values were reported as mean ± standard deviation 
(SD) of three replicates. Data were analyzed using one-
way analysis of variance (ANOVA) followed by Dunnett’s 
test to determine statistical significance. GraphPad Prism 
5 software (GraphPad Software Inc. San Diego, CA) was 
used for all statistical analyses as well as for IC50 values.
RESULTS AND DISCUSSION
EVALUATION OF ANTIOXIDANT ACTIVITY 
Methanolic extracts of leaves, barks, twigs and roots of E. 
pulchrum were investigated for antioxidant activity. The 
results of ferric reducing power are presented in Figure 
1. In this study, the bark extract showed strong ability in 
reducing Fe3+ to Fe2+ with 1491.4 ± 0.03 μmol/L followed 
by root and twig extracts (1078.1 ± 0.03 and 941.1 ± 0.03 
μmol/L, respectively). Meanwhile, the leaves extract 
FIGURE 1. Reducing power activity of the crude methanol extract of E. pulchrum. *p<0.05 
indicates no significant difference compared to the positive control
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exhibited the lowest FRAP value was 91.6 ± 0.01 μmol/L. 
The radical scavenging activity using DPPH was tested for 
all extracts (Figure 2). Inhibitory activity was calculated 
in the following order: barks extract (60.4 ± 0.02%), twigs 
extract (55.8 ± 0.05%) roots extract (20.2 ± 0.01%) and 
leaves extract (7.34 ± 0.04%). Percentage inhibition of 
more than 50% was calculated for their IC50 values (Table 
1). The IC50 results showed that barks and twigs exhibited 
weak of free radical scavenging activities of 430.0 ± 0.04 
and 640.0 ± 0.05 μg/mL compared with ascorbic acid 
(70.0 ± 0.23 μg/mL) as a positive control. The antioxidant 
results obtained from the E. pulchrum extracts may be 
due to the presence of phenolic compounds in the extract. 
Phenolic compounds have been known as antioxidant 
and scavenging agents against free radicals associated 
with oxidative damage (Fergusion et al. 2006). This 
was supported by previous studies which demonstrated 
the strong antioxidant activity of phenolic compounds 
against diseases associated with oxidative stress. Phenolic 
compounds such as (+)-catechin and (-)-epicatechin were 
found to be the most active with IC50 values  of 4.16 and 
4.67 μM for DPPH and 190 and 170 μM for nitric oxide 
scavenging activities (Kirmizibekmez et al. 2009). A recent 
study of phenolic compounds and antioxidant activity 
reported that isoflavone aglycones (genistein, daidzein 
and glycitein), isoflavone β-glucosides (genistin, daidzin 
and glycitin) and phenolic acids also contribute to the 
antioxidant activity (Lee et al. 2013). Thus, the presence 
of phenolic compounds as the best electron donors can 
eliminate the radical chain reaction by converting free 
radicals to more stable products (Mbaebie et al. 2012).
EVALUATION OF ANTICANCER ACTIVITY
The cytotoxic activity was determined by a tetrazolium 
(MTT) assay. The results of all extracts are presented in 
Table 2. The cell survival decreased in a dose-dependent 
manner. Three extracts of leaves, twigs and roots exhibited 
very low IC50 values on breast cancer cell (MCF-7), ovarian 
cancer cell (CAOV-3) and myelomonocytic leukaemia cell 
lines (WEHI-3), confirming these extracts had the highest 
toxicity. Leaves extracts were shown to be more active on 
MCF-7 cell line (IC50: 7.8 ± 0.85 μg/mL) and WEHI-3 cell 
line (IC50: 9.0 ± 0.13 μg/mL) while twigs and roots were 
active on CAOV-3 cell line (IC50: 13.8 ± 0.35 and 7.3 ± 0.98 
μg/mL). Methanolic extracts of E. pulchrum did not show 
any toxicity effects on normal hepatic cells (WRL-68) up to 
100 μg/mL. Findings from this study showed extracts from 
leaves, twigs and roots may contain bioactive compounds 
that demonstrate their potential to be an anticancer drug. 
Based on cytotoxicity screening results on all cancer cell 
lines tested, these extracts exhibited very low IC50 on breast 
cancer cells and myelomonocytic leukaemia cells (leaves) 
as well as ovarian cancer cells (twigs and roots). Both 
type of cancer except myelomonocytic leukaemia are the 
most common cancer in women. Thus, this plant has the 
potential to treat cancer that effects women. Meanwhile, 
phytochemical studies carried out by Lavault et al. (1990) 
and Nordin et al. (2012) found that chemical compounds 
present in E. pulchrum are alkaloids. This group of 
compound has been shown to be highly active against 
several cancer cell (Lu et al. 2012). In fact, alkaloids are 
among the most important active components in natural 
TABLE 1. The IC50 values of DPPH assay of active extracts of E. 
pulchrum. All values represent means ± SD of three replicates
Samples IC50 (μg/mL)
Ascorbic acid
Bark
Twig
70.0 ± 0.23
430.0 ± 0.04
640.0 ± 0.05
FIGURE 2. Effect of different extracts of E. pulchrum on DPPH scavenging activity. 
Data represent means ± SD of three replicates
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herbs and some of these compounds have already been 
successfully developed into chemotherapeutic drugs, such 
as vinblastine, which interacts with tubulin (Li et al. 2007), 
camptothecin (CPT) and a famous topoisomerase I (TopI) 
inhibitor (Huang et al. 2007). Several alkaloids isolated 
from this plant also showed anticancer activity in human 
breast and lung cancer cell lines including asimilobine, 
annonaine and liriodenine (Yeh et al. 2011). Among these 
alkaloids, liriodenine exhibited highly active anticancer 
activity against both cancer cell line (Yeh et al. 2011). 
Therefore, the bioactive compounds which consist of 
alkaloids may contribute to the anticancer activity.
EVALUATION OF ANTIMICROBIAL ACTIVITY
The inhibition zone produced by E. pulchrum extracts 
against ten bacteria and two fungi can be seen in Tables 
3 and 5. Bark and twig extracts displayed high inhibitory 
zones against B. subtilis at 13.33 ± 0.57 and 12.0 ± 0.01 
mm, respectively. However, none of the extracts exhibit 
activity against E. cloacae and P. aeruginosa. The two 
extracts showing highest inhibition zone were subjected 
to MIC and MBC tests against B. subtilis. The MIC and MBC 
values of twigs extract were lower than that of the bark 
extract (MIC 0.5 and 1.0 mg/mL, MBC 1.0 and 2.0 mg/mL, 
respectively) (Table 4). This could be due to the presence 
of specific groups in the compounds of the extracts. 
Meanwhile, the results of antifungal activity exhibited only 
leaves and twig extracts gave the same inhibition value (9.0 
mm) against C. albicans. Based on the results, all extracts 
showed activity against all tested bacteria and fungi except 
E. cloacae, P. aeruginosa and A. niger. It is interesting 
to note that conventional drugs in use are more active 
against Gram-positive than Gram-negative bacterial strains 
(Mewari & Kumar 2008). Lin et al. (1999) also reported 
that the plant extracts are usually more active against 
Gram-positive than Gram-negative bacteria. This may 
be due to the higher resistance of Gram-negative bacteria 
against antibodies because of their impenetrable cell wall. 
In addition, lipopolysaccharide (LPS) content possesed by 
Gram-negative bacteria also contribute to its resistivity. 
There are many studies that showed the significant effect 
of plant extracts against Gram-positive compared with 
Gram-negative bacteria, such as antibacterial activity of 
extracts from plants in central Argentina (Joray et al. 2011) 
and evaluation of various crude extracts of Zingiber ficinale 
rhizome for potential antibacterial activity (Kaushik & 
Goyal 2011). Our findings also exhibited the extract of E. 
pulchrum were more active towards Gram-positive bacteria 
(B. cereus, B. subtilis and S. aureus) than Gram-negative 
TABLE 2. Effect of methanolic extracts of E. pulchrum on several cell lines
IC50 μg/mL MCF-7 MDA-
MB231
HEPG2 HT-29 CCD841 SKOV-3 CAOV-3 PC3 WEHI-3B HL-60 WRL-68
Leaves 7.8±0.85 >50 >50 49.5 >50 >50 >50 >50 9.0±0.13 >50 94.5
Twigs >50 44.6 >50 >50 >50 >50 13.9±0.35 >50 >50 >50 >100
Barks 43.2±1.69 37.2±9.05 >50 48.4 >50 >50 37.2±6.15 >50 31.0±0.11 36.0±0.01 99
Roots >50 46.8 >50 >50 >50 >50 7.3±0.98 47.1 >50 >50 99.5
Tamoxifen 1.01±1.21 6.68±1.34 - 30.3±2.1 - - - - - - -
Paclitaxel - - - - 33.2±1.3 4.3±0.3 <0.79±0.1 0.3±0.1 26.8±1.13
Vinblastin - - - - - - - - 2.0+1.2 1.8±0.1 -
Cisplatin - - 25.6±1.3 - - - - - - - -
*All values represent means ± SD of three replicates
TABLE 3. Inhibition diameter of E. pulchrum methanolic extracts against ten bacterial strains
Bacterial strains / Extracts
Inhibition diameter (mm)
Leaves Barks Twigs Roots Streptomycin
B. cereus 
B. subtilis
E. cloacae
S. aureus (S1434)
S. typhimurium
P. aeruginosa
K. pneumoniae
S. aureus (27853)
P. multocida
S. epidermidis
7±0
7±0
NI
8.33±0.57
8±0
NI
8±0
7±0
9±0
7±0
7±0
13.33±0.57
NI
8.33±0.57
8.66±0.57
NI
7.66±0.57
NI
8.6±0.57
7.3±0.57
7.33±0.57
12±0
NI
8±0
8.66±0.57
NI
7.66±0.57
NI
9±0
7.6±0.57
NI
NI
NI
NI
NI
NI
8±0
NI
NI
NI
35.0±0
35.0±0
22.0±0
20.0±0
16.0±0
-
24±0
20.33±0
24±0
22.0±0
* All values represent means ± SD of three replicates. NI – no inhibition observed
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bacteria (E. cloacae, S. typhimurium, P. aeruginosa, K. 
pneumoniae, P. multocida and S. epidermidis).
CONCLUSION
The results indicated that leaves, twig and root extracts of 
E. pulchrum may contain promising therapeutic anticancer 
but not antioxidant and antimicrobial properties. At 
present, the isolation study is being conducted to purify 
the compounds from the active extracts.
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NI
NI
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